About Triochem Products Limited
Data last updated:
Triochem Products Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 07 January 1972 and has been in existence for over 54 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN L24249MH1972PLC015544. Its GSTIN is 27AAACT2202J1ZO (Maharashtra). Its shares are listed on BSE: 512101.
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹24.5 Lakh. It is led by directors including Grace Ramu Deora and Ramu Sitaram Deora.
Its last annual general meeting (AGM) was held on 25 June 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Sambhava Chambers4Th Floor Sir P M Road, Mumbai, Maharashtra, India – 400001.
The net worth stands at ₹20.65 Cr (up 51.1% YoY). Total assets are valued at ₹20.65 Cr (up 51.1% YoY).
The company has about 10 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Triochem Products. As per MCA filings, the company has open charges of ₹16.24 Cr and satisfied charges of ₹16.24 Cr on record. The company has 4 deals on record (4 market trades); the latest was in September 2012.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website triochemproducts.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressSambhava Chambers4Th Floor Sir P M Road, Mumbai, Maharashtra, India – 400001
- IndustryPharma, API Manufacturers
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Triochem Products Limited
The main business activity of Triochem Products is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Triochem Products Limited FY 2025-26 filings available
Triochem Products Limited reported revenue of ₹- for FY 2025-26.
Financial Highlights
FY 2025-26 · StandaloneRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 8.82 | 13.94 | 20.03 |
| Revenue growth | - | - | - | -100.0% | -36.7% | -30.4% | - |
| EBITDA | (1.36) | (1.21) | (2.27) | (1.35) | 1.33 | (0.37) | 4.55 |
| EBITDA margin | - | - | - | - | +15.1% | -2.7% | +22.7% |
| Profit before tax | 10.52 | (0.24) | (1.33) | (1.18) | 1.75 | (0.59) | 4.55 |
| Net profit | (5.93) | (0.85) | (0.12) | (0.97) | 1.31 | (0.45) | 3.40 |
| Net profit margin | - | - | - | - | +14.9% | -3.2% | +17.0% |
| EPS (₹) | 325.33 | (16.34) | (41.36) | (36.13) | 53.99 | (18.24) | 138.89 |
| Balance sheet | |||||||
| Total assets | 20.65 | 13.67 | 14.62 | 11.60 | 13.05 | 11.71 | 14.68 |
| Net worth | 20.65 | 13.67 | 14.63 | 11.60 | 13.05 | 11.72 | 12.18 |
| Total debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.50 |
| Cash & bank | 11.73 | 0.91 | 0.54 | 0.96 | 11.81 | 8.20 | 0.55 |
| Net working capital | 12.96 | 2.31 | 2.45 | 1.04 | 11.83 | 10.61 | 13.51 |
| Cash flow | |||||||
| Cash from operations | (2.87) | 0.20 | (3.76) | (1.58) | 3.47 | 10.25 | 3.82 |
| Cash from investing | 13.70 | 0.17 | 3.34 | (9.27) | 0.16 | 0.00 | (0.03) |
| Cash from financing | 0.00 | 0.00 | 0.00 | 0.00 | (0.02) | (2.61) | (3.49) |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other income | 0.17 | 11.29 | 0.22 | 0.30 | 0.22 | 0.32 | 0.46 | 0.27 |
| Total expenses | 0.04 | 0.22 | 0.38 | 0.42 | 0.36 | 0.33 | 0.59 | 0.30 |
| EBITDA | (0.04) | (0.22) | (0.38) | (0.42) | (0.36) | (0.33) | (0.59) | (0.30) |
| Depreciation | 0.00 | 0.00 | 0.01 | 0.02 | 0.02 | 0.02 | 0.04 | 0.02 |
| Interest | 0.00 | 0.08 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.13 | 10.99 | (0.17) | (0.14) | (0.16) | (0.03) | (0.17) | (0.05) |
| Tax | 0.03 | 2.66 | (0.04) | 0.05 | (0.12) | 0.42 | (0.25) | (0.01) |
Financial Statements
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other income | 0.17 | 11.29 | 0.22 | 0.30 | 0.22 | 0.32 | 0.46 | 0.27 |
| Total expenses | 0.04 | 0.22 | 0.38 | 0.42 | 0.36 | 0.33 | 0.59 | 0.30 |
| EBITDA | (0.04) | (0.22) | (0.38) | (0.42) | (0.36) | (0.33) | (0.59) | (0.30) |
| Depreciation | 0.00 | 0.00 | 0.01 | 0.02 | 0.02 | 0.02 | 0.04 | 0.02 |
| Interest | 0.00 | 0.08 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.13 | 10.99 | (0.17) | (0.14) | (0.16) | (0.03) | (0.17) | (0.05) |
| Tax | 0.03 | 2.66 | (0.04) | 0.05 | (0.12) | 0.42 | (0.25) | (0.01) |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 8.82 | 13.94 | 20.03 |
| Revenue growth | - | - | - | -100.0% | -36.7% | -30.4% | - |
| Other income | 12.03 | 1.05 | 1.03 | 0.28 | 0.56 | 0.13 | 0.47 |
| Total expenses | 1.36 | 1.21 | 2.27 | 1.35 | 7.49 | 14.31 | 15.48 |
| Employee cost | 0.53 | 0.59 | 0.47 | 0.52 | 0.50 | 0.67 | 0.82 |
| EBITDA | (1.36) | (1.21) | (2.27) | (1.35) | 1.33 | (0.37) | 4.55 |
| EBITDA margin | - | - | - | - | +15.1% | -2.7% | +22.7% |
| Depreciation | 0.05 | 0.08 | 0.09 | 0.11 | 0.12 | 0.14 | 0.17 |
| Interest | 0.10 | 0.00 | 0.00 | 0.00 | 0.02 | 0.21 | 0.30 |
| Profit before tax | 10.52 | (0.24) | (1.33) | (1.18) | 1.75 | (0.59) | 4.55 |
| Tax | 2.54 | 0.15 | (0.32) | (0.29) | 0.44 | (0.14) | 1.15 |
| Net profit | (5.93) | (0.85) | (0.12) | (0.97) | 1.31 | (0.45) | 3.40 |
| Net profit margin | - | - | - | - | +14.9% | -3.2% | +17.0% |
| EPS (₹) | 325.33 | (16.34) | (41.36) | (36.13) | 53.99 | (18.24) | 138.89 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 |
| Reserves & surplus | 20.40 | 13.42 | 14.38 | 11.35 | 12.80 | 11.47 | 11.93 |
| Shareholders' funds (net worth) | 20.65 | 13.67 | 14.63 | 11.60 | 13.05 | 11.72 | 12.18 |
| Secured loans | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.25 |
| Unsecured loans | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.25 |
| Total debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.50 |
| Total liabilities | 20.65 | 13.67 | 14.62 | 11.60 | 13.05 | 11.71 | 14.68 |
| Assets | |||||||
| Gross block | 0.00 | 2.03 | 2.03 | 2.03 | 2.02 | 1.97 | 1.95 |
| Net block | 0.00 | 0.60 | 0.68 | 0.77 | 0.87 | 0.94 | 1.06 |
| Capital work in progress | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 0.03 |
| Investments | 7.89 | 10.63 | 11.07 | 9.42 | 0.00 | 0.00 | 0.00 |
| Inventories | 0.00 | 0.00 | 0.05 | 0.05 | 0.05 | 0.85 | 1.55 |
| Sundry debtors | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.39 | 12.40 |
| Cash & bank balances | 11.73 | 0.91 | 0.54 | 0.96 | 11.81 | 8.20 | 0.55 |
| Loans & advances | 1.26 | 1.62 | 2.13 | 0.27 | 0.18 | 0.56 | 0.86 |
| Total current assets | 12.99 | 2.53 | 2.72 | 1.28 | 12.04 | 11.00 | 15.36 |
| Total current liabilities | 0.03 | 0.22 | 0.27 | 0.24 | 0.21 | 0.39 | 1.85 |
| Net working capital | 12.96 | 2.31 | 2.45 | 1.04 | 11.83 | 10.61 | 13.51 |
| Total assets | 20.65 | 13.67 | 14.62 | 11.60 | 13.05 | 11.71 | 14.68 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 0.91 | 0.54 | 0.96 | 11.81 | 8.20 | 0.55 | 0.25 |
| Net cash from operating activities | (2.87) | 0.20 | (3.76) | (1.58) | 3.47 | 10.25 | 3.82 |
| Net cash from investing activities | 13.70 | 0.17 | 3.34 | (9.27) | 0.16 | 0.00 | (0.03) |
| Net cash from financing activities | 0.00 | 0.00 | 0.00 | 0.00 | (0.02) | (2.61) | (3.49) |
| Net change in cash | 10.82 | 0.37 | (0.42) | (10.85) | 3.61 | 7.64 | 0.30 |
| Closing cash | 11.73 | 0.91 | 0.54 | 0.96 | 11.81 | 8.20 | 0.55 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | - | - | - | -100.0% | -36.7% | -30.4% | - |
| EBITDA growth | -12.4% | +46.7% | -68.2% | -201.5% | +459.5% | -108.1% | - |
| PBT growth | +9998.0% | +82.0% | -12.7% | - | +9998.0% | - | +333.3% |
| Net income growth | -597.7% | -608.3% | +87.6% | -174.1% | +391.1% | -113.2% | - |
| Revenue CAGR (3Y) | - | -100.0% | -100.0% | -100.0% | -10.6% | -26.4% | +3.5% |
| EBITDA CAGR (3Y) | +0.3% | - | +83.1% | - | -7.1% | - | +66.3% |
| Profitability & leverage | |||||||
| Net income margin | - | - | - | - | +14.9% | -3.2% | +17.0% |
| Return on capital employed | -4.3% | -3.3% | -2.7% | -9.5% | +14.4% | -2.8% | +33.2% |
| Return on net worth | -34.6% | -6.1% | -0.9% | -7.2% | +10.7% | -3.8% | +32.4% |
| Debt / equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.10 | 0.40 |
| Long-term debt / equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest cover | -7.09 | 0.00 | 0.00 | 0.00 | 1.65 | -41.18 | 6.85 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 0.00 | 0.00 | 0.00 | 0.00 | 4.42 | 7.11 | 10.27 |
| Inventory turnover | 0.00 | 0.00 | 0.00 | 0.00 | 19.60 | 11.62 | 3.60 |
| Debtors turnover | 0.00 | 0.00 | 0.00 | 0.00 | 12.69 | 2.02 | 2.55 |
| EPS (₹) | 325.33 | (16.34) | (41.36) | (36.13) | 53.99 | (18.24) | 138.89 |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 842.78 | 557.83 | 596.74 | 473.36 | 532.51 | 478.04 | 497.00 |
Auditor Details of Triochem Products Limited
Triochem Products Limited is audited by Kanu Doshi Associates LLP for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Kanu Doshi Associates LLP | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Triochem Products Limited
Triochem Products has 6 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Grace Ramu Deora Also directs: G Amphray Pharmaceuticals Private Limited, Triochem Laboratories Pvt Ltd, Ambernath Plasto Packaging Pvt Ltd and 1 more | Director | 30 Mar 2015 | 11 Years 6 Months | Current |
| Ramu Sitaram Deora Also directs: Deora Investments Private Limited, G Amphray Laboratories LLP | Director | 30 Jun 1975 | 51 Years 3 Months | Current |
| Shyam Sundar Sharma | Director | 28 May 1985 | 41 Years 4 Months | Current |
| Rajesh Ramu Deora Also directs: G Amphray Pharmaceuticals Private Limited, Triochem Laboratories Pvt Ltd, Ambernath Plasto Packaging Pvt Ltd and 1 more | Director | 28 May 2019 | 7 Years 4 Months | Current |
| Vipul Amul Desai Also directs: Sonal Adhesives Limited, National Plastic Industries Limited, Salvi Chemical Industries Limited and 1 more | Director | 29 Mar 2025 | 1 Years 6 Months | Current |
| Shailendra Mishra Also directs: SM Hospitality & Events LLP, TVC Business Network LLP, Epuja Spiritech Limited and 1 more | Director | 29 Mar 2025 | 1 Years 6 Months | Current |
Shareholding Pattern of Triochem Products Limited
Shareholding for the quarter ended Mar 2026: promoters hold 68.60%, foreign institutional investors hold 0.00%, domestic institutional investors hold 0.00% and retail and other public shareholders hold 31.40%.
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | |
|---|---|---|---|---|
| Promoters | 68.60% | 68.60% | 68.60% | 68.60% |
| Public | 31.40% | 31.40% | 31.40% | 31.40% |
Charges & Borrowings of Triochem Products Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Sep 2012 | State Bank of India | ₹16.24 Cr | Satisfied |
Total charge records: 1 View all charges
Deals & Funding of Triochem Products Limited
Triochem Products Limited has 4 deals on record (4 market trades); the latest was in September 2012.
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2012 | Market trade | ₹2 Lakh | Buyer: Mehrangarh Financial Advisors Private Limited Seller: an individual |
| Aug 2012 | Market trade | ₹1.2 Lakh | Buyer: Ambernath Plasto Packaging Pvt Ltd Seller: an individual |
| Jul 2012 | Market trade | ₹1.2 Lakh | Buyer: Rapid Stocks Private Limited , N L Rungta Huf Seller: 2 individuals |
| May 2012 | Market trade | ₹30,000 | Seller: an individual |
Full deal history
All 4 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Associated Brands with Triochem Products Limited
Triochem Products operates one associated brand: Triochem Products. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturer and exporter of pharmaceutical bulk drugs and chemicals in India. | triochemproducts.com |
Competitors & Alternatives of Triochem Products Limited
Brands and companies operating in the same space as Triochem Products Limited include Laurus Labs, Symbiotec, Beijing Biostar Technologies and 6 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
 Laurus Labs | Pharmaceutical and biotechnology company | Hyderabad, India | 2005 |
 Symbiotec | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | Indore, India | 2002 |
 Beijing Biostar Technologies | APIs, intermediates, and biochemical reagents are developed and manufactured. | Beijing, China | 2002 |
 Sterling Pharma Solutions | Contract development, manufacturing, and analytical services for APIs are offered. | Dudley, United Kingdom | 2016 |
 Provepharm Life Solutions | APIs and drug products are developed and valorized in pharmaceuticals. | Marseille, France | 1998 |
 Hikal | APIs and intermediates are produced via custom synthesis and research. | Mumbai, India | 1988 |
 Snapdragon Chemistry | Drug discovery and development service provider | Cambridge, United States | 2014 |
 SeQuent | APIs are developed and manufactured for therapeutic areas. | Bengaluru, India | 2002 |
 Jubilant Pharma | Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company. | Noida, India | 1978 |
Employees and EPFO Compliance at Triochem Products Limited
Triochem Products Limited has a workforce of 10 employees as of Apr 09, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Triochem Products Limited
Triochem Products has one previous CIN (Corporate Identification Number): U24249MH1972PLC015544. The current CIN is L24249MH1972PLC015544, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L24249MH1972PLC015544 | Current |
| U24249MH1972PLC015544 | Previous |
Recent Activity on Triochem Products Limited
Credit Ratings, Litigation & Regulatory Alerts for Triochem Products Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Triochem Products Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Triochem Products Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Triochem Products Limited
Triochem Products has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACT2202J1ZO | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Triochem Products Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Triochem Products Limited
Triochem Products is an active public limited company based in Mumbai, Maharashtra, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 07 January 1972 (54+ years old) and is registered under CIN L24249MH1972PLC015544. Listed on BSE: 512101.
Triochem Products has 6 current directors:
- Grace Ramu Deora - Director
- Ramu Sitaram Deora - Director
- Shyam Sundar Sharma - Director
- Rajesh Ramu Deora - Director
- Vipul Amul Desai - Director
- Shailendra Mishra - Director
The GSTIN of Triochem Products is 27AAACT2202J1ZO, registered in Maharashtra.
The CIN (Corporate Identification Number) of Triochem Products is L24249MH1972PLC015544. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Triochem Products is listed on BSE with code 512101.
Triochem Products was incorporated on 07 January 1972, making it 54+ years old. It is registered with the Registrar of Companies, Mumbai.
Triochem Products has 4 deals on record (4 market trades); the latest was in September 2012.
Triochem Products can be reached through the website triochemproducts.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Triochem Products is at Sambhava Chambers4Th Floor Sir P M Road, Mumbai, Maharashtra, India – 400001.